July 2, 2024 July 2, 2024Categories New TrialsNow Enrolling: This myeloMATCH trial is testing a new treatment for patients with acute myeloid leukemia that has a FLT3-ITD or D835 mutationThis study compares a standard initial treatment with a new approach that has the potential to put more patients into remission
March 26, 2024 March 26, 2024Categories New TrialsNow Enrolling: ComboMATCH treatment trial E5 is testing a new option for patients with advanced solid tumors that have a KRAS G12C mutationThis study is assessing the combination of two drugs—sotorasib and panitumumab—in patients with KRAS G12C-mutated solid tumors
July 19, 2023 July 19, 2023Categories Editorials7 ways advocates have enhanced ECOG-ACRIN’s cancer research programECOG-ACRIN’s cancer research advocates recently reflected on their committee’s key accomplishments
July 19, 2023 July 19, 2023Categories New TrialsNow Enrolling: ComboMATCH treatment trial E4 is testing a new option for patients with advanced solid tumors that progress despite taxane chemotherapyThis study is for patients with solid tumors that are progressing after treatment with taxane therapies